Home > Financial Ratios > ADVANCED ENZYME TECHNOLOGIES

ADVANCED ENZYME TECHNOLOGIES
Core EBITDA Growth

    Back to All Ratios
ADVANCED ENZYME TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ADVANCED ENZYME TECHNOLOGIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.6832.44-12.46-13.4315.51

What is the latest Core EBITDA Growth ratio of ADVANCED ENZYME TECHNOLOGIES ?

The latest Core EBITDA Growth ratio of ADVANCED ENZYME TECHNOLOGIES is -5.68 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.68
Mar202432.44
Mar2023-12.46
Mar2022-13.43
Mar202115.51

How is Core EBITDA Growth of ADVANCED ENZYME TECHNOLOGIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.68
Negative
Mar2024 32.44
Positive
Mar2023 -12.46
Negative
Mar2022 -13.43
Negative
Mar2021 15.51 -

Other Financial Ratios of ADVANCED ENZYME TECHNOLOGIES


Compare Core EBITDA Growth ratio of peers of ADVANCED ENZYME TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES ₹3,211.5 Cr 8.1% -8.1% -15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES

8.1%

-8.1%

-15.6%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses